Table 3. The effects of Cuc IIa on mouse H22 liver cancer through vein injectiona.
| Dosage | Administration method | Animal number | Animal body weight (g) | Cancer weight (g) | Inhibition | |
|---|---|---|---|---|---|---|
| Sample | (mg kg−1 per day) | Ig × 10qd | Start/end | Start/end | X±s.d. | efficiency |
| Cuc IIa | 15 | Ig × 10qd | 10/10 | 19.5/25.3 | 1.48±0.11 | 55.02 |
| Cuc IIa | 10 | Ig × 10qd | 10/10 | 19.3/25.9 | 1.76±0.08 | 44.12 |
| Cuc IIa | 5 | Ig × 10qd | 10/10 | 19.4/25.1 | 2.13±0.20 | 32.38 |
| Control | Solvent | Ig × 10qd | 10/10 | 19.4/26.0 | 3.15±0.44 |
a
Compared with negative control, P<0.01. The difference is significant.